Michael Teifel
Directeur Technique/Scientifique/R&D chez AETERNA ZENTARIS INC.
Fortune : - $ au 30/04/2024
Profil
Michael Teifel is the founder of Munich Biotech AG, which was founded in 1998.
He held the title of Head-Pharmacology & Toxicology from 1998 to 2004.
Currently, Dr. Teifel is the Chief Scientific Officer & Senior Vice President at Æterna Zentaris, Inc. since 2004.
He is also the Head-Translational Sciences at Cleara Biotech BV.
Previously, Dr. Teifel worked at AEterna Zentaris GmbH from 2004 to 2019, where he held the title of Vice President-Non Clinical Services from 2014 to 2019.
Dr. Teifel obtained his doctorate degree from Technische Universität Darmstadt in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 12/01/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Michael Teifel
| Sociétés | Poste | Début |
|---|---|---|
| AETERNA ZENTARIS INC. | Directeur Technique/Scientifique/R&D | 03/05/2021 |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Corporate Officer/Principal | - |
Anciens postes connus de Michael Teifel
| Sociétés | Poste | Fin |
|---|---|---|
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Corporate Officer/Principal | 01/10/2019 |
Munich Biotech AG
 Munich Biotech AG Pharmaceuticals: MajorHealth Technology Munich Biotech AG manufactures pharmaceuticals. The private company is based in Neuried, Germany. The German company was founded by Michael Teifel. | Fondateur | 01/08/2004 |
Formation de Michael Teifel
| Technische Universität Darmstadt | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Munich Biotech AG
Munich Biotech AG Pharmaceuticals: MajorHealth Technology Munich Biotech AG manufactures pharmaceuticals. The private company is based in Neuried, Germany. The German company was founded by Michael Teifel. | Health Technology |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Commercial Services |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |
